Pharmacogenomics in cardiovascular disease: focus on aspirin and ADP receptor antagonists-Reference-Cited by-同舟云学术

Pharmacogenomics in cardiovascular disease: focus on aspirin and ADP receptor antagonists

Published:2013-09 Issue:9 Volume:11 Page:1627-1639
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Würtz M.¹,Lordkipanidzé M.²,Grove E. L.¹

Affiliation:

1. Department of Cardiology; Aarhus University Hospital; Aarhus Denmark

2. Centre for Cardiovascular Sciences; Institute of Biomedical Research; College of Medical and Dental Sciences; University of Birmingham; Birmingham UK

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.12318/fullpdf

Reference102 articles.

1. Platelet function testing in atherothrombotic disease;Grove;Curr Pharm Des,2012

2. Response variability to clopidogrel: is tailored treatment, based on laboratory testing, the right solution?;Cattaneo;J Thromb Haemost,2012

3. Interindividual variability in the efficacy of oral antiplatelet drugs: definitions, mechanisms and clinical importance;Wurtz;Curr Pharm Des,2012

4. Genetic and environmental contributions to platelet aggregation: the Framingham heart study;O'Donnell;Circulation,2001

5. Genomic medicine-a primer;Guttmacher;N Engl J Med,2002

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithrombotic Treatment for Chronic Coronary Syndrome: Evidence and Future Perspectives;Cardiology;2024-02-14

2. Predictors of late complications in pregnant women with arterial hypertension;Journal of obstetrics and women's diseases;2023-02-07

3. Evidence on the Impact of Pharmacogenetics to Treat and Manage Cardiovascular Diseases;Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy;2023

4. Evidence on the Impact of Pharmacogenetics to Treat and Manage Cardiovascular Diseases;Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy;2023

5. Taqman-MGB FQ-PCR for Human GPIIIa, GP1BA and PEAR1 SNPs;Clinical Laboratory;2022